Geoestatística na avaliação dos atributos físicos em latossolo sob floresta nativa e pastagem na Região de Manicoré, Amazonas

The use of geostatistical techniques allows detection of the existence of dependence and the spatial distribution of soil properties, thus constituting an important tool in the analysis and detailed description of the behavior of soil physical properties. The aim of the present study was to use geostatistics in assessment of physical properties in a Latossolo (Oxisol) dystrophic under native forest and pasture in the Amazon region of Manicore. Grids with of 70 x 70 m were established in native forest and pasture, and points were marked in these grids spaced at every 10 m, for a total of 64 points. These points were then georeferenced and in each one, soil samples (128) were collected at the depths of 0.00-0.20 and 0.40-0.60 m for a survey of their physical properties. These grids are parallel at a distance of 100 m from one another. The following determinations were made: texture, bulk density and particle density, macroporosity, microporosity, total porosity and aggregate stability in water. After tabulating the data, descriptive statistical analysis and geostatistical analysis were performed. The pasture had a slight variation in its physical properties in relation to native forest, with a high coefficient of variation and weak spatial dependence. The scaled semivariograms were able to satisfactorily reproduce the spatial behavior of the properties in the same pattern as the individual semivariograms, and the use of the parameter range of the semivariogram was efficient for determining the optimal sampling density for the environments under study. The geostatistical results indicate that the removal of native forest for establishing pasture altered the natural variability of the physical properties.A utilização das técnicas geoestatísticas permite detectar a existência da dependência e distribuição espacial dos atributos do solo, constituindo importante ferramenta na análise e descrição detalhada do comportamento dos atributos físicos do solo. Este trabalho teve como objetivo o uso da geoestatística na avaliação dos atributos físicos em Latossolo sob floresta nativa e pastagem na região de Manicoré no Amazonas. Nas áreas de floresta nativa e pastagem, foram estabelecidas malhas com dimensão 70 × 70 m e demarcados pontos nessas malhas espaçados a cada 10 m, totalizando 64 pontos. Esses pontos foram georreferenciados e, em seguida, foram feitas as coletadas de solo em cada ponto da malha nas camadas de 0,00-0,20 e 0,40-0,60 m para determinação dos atributos físicos, totalizando 128 amostras de solo em cada malha. Essas malhas encontram-se paralelas com uma distância uma da outra de 100 m e o solo nessas áreas é classificado como Latossolo. Determinaram-se textura, densidade do solo e de partículas, macroporosidade, microporosidade, porosidade total e estabilidade dos agregados em água. Após a tabulação dos dados, foram realizadas análises estatísticas descritivas e geoestatística. A pastagem apresentou leve variação nos seus atributos físicos em relação à floresta nativa, com coeficiente de variação alto e dependência espacial fraca. Os semivariogramas escalonados conseguiram reproduzir de forma satisfatória o comportamento espacial dos atributos no mesmo padrão dos semivariogramas individuais, e o uso do parâmetro alcance do semivariograma mostrou-se eficiente para determinar a densidade amostral ideal para os ambientes em estudo. Os resultados geoestatísticos indicaram que a retirada da floresta nativa para a implantação da pastagem alterou a variabilidade natural dos atributos físicos.UNESP Faculdade de Ciências Agrárias e VeterináriasUFAM Instituto de Educação, Agricultura e AmbienteUNESP FCAV Departamento de Solos e AdubosUniversidade Federal do Acre Programa de Pós-graduação em Ciência, Inovação e Tecnologia para a AmazôniaUNESP Faculdade de Ciências Agrárias e VeterináriasUNESP FCAV Departamento de Solos e Adubo

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Background The major complication of COVID-19 is hypoxaemic respiratory failure from capillary leak and alveolar oedema. Experimental and early clinical data suggest that the tyrosine-kinase inhibitor imatinib reverses pulmonary capillary leak.Methods This randomised, double-blind, placebo-controlled, clinical trial was done at 13 academic and non-academic teaching hospitals in the Netherlands. Hospitalised patients (aged >= 18 years) with COVID-19, as confirmed by an RT-PCR test for SARS-CoV-2, requiring supplemental oxygen to maintain a peripheral oxygen saturation of greater than 94% were eligible. Patients were excluded if they had severe pre-existing pulmonary disease, had pre-existing heart failure, had undergone active treatment of a haematological or non-haematological malignancy in the previous 12 months, had cytopenia, or were receiving concomitant treatment with medication known to strongly interact with imatinib. Patients were randomly assigned (1:1) to receive either oral imatinib, given as a loading dose of 800 mg on day 0 followed by 400 mg daily on days 1-9, or placebo. Randomisation was done with a computer-based clinical data management platform with variable block sizes (containing two, four, or six patients), stratified by study site. The primary outcome was time to discontinuation of mechanical ventilation and supplemental oxygen for more than 48 consecutive hours, while being alive during a 28-day period. Secondary outcomes included safety, mortality at 28 days, and the need for invasive mechanical ventilation. All efficacy and safety analyses were done in all randomised patients who had received at least one dose of study medication (modified intention-to-treat population). This study is registered with the EU Clinical Trials Register (EudraCT 2020-001236-10).Findings Between March 31, 2020, and Jan 4, 2021, 805 patients were screened, of whom 400 were eligible and randomly assigned to the imatinib group (n=204) or the placebo group (n=196). A total of 385 (96%) patients (median age 64 years [IQR 56-73]) received at least one dose of study medication and were included in the modified intention-to-treat population. Time to discontinuation of ventilation and supplemental oxygen for more than 48 h was not significantly different between the two groups (unadjusted hazard ratio [HR] 0.95 [95% CI 0.76-1.20]). At day 28, 15 (8%) of 197 patients had died in the imatinib group compared with 27 (14%) of 188 patients in the placebo group (unadjusted HR 0.51 [0.27-0.95]). After adjusting for baseline imbalances between the two groups (sex, obesity, diabetes, and cardiovascular disease) the HR for mortality was 0.52 (95% CI 0.26-1.05). The HR for mechanical ventilation in the imatinib group compared with the placebo group was 1.07 (0.63-1.80; p=0.81). The median duration of invasive mechanical ventilation was 7 days (IQR 3-13) in the imatinib group compared with 12 days (6-20) in the placebo group (p=0.0080). 91 (46%) of 197 patients in the imatinib group and 82 (44%) of 188 patients in the placebo group had at least one grade 3 or higher adverse event. The safety evaluation revealed no imatinib-associated adverse events.Interpretation The study failed to meet its primary outcome, as imatinib did not reduce the time to discontinuation of ventilation and supplemental oxygen for more than 48 consecutive hours in patients with COVID-19 requiring supplemental oxygen. The observed effects on survival (although attenuated after adjustment for baseline imbalances) and duration of mechanical ventilation suggest that imatinib might confer clinical benefit in hospitalised patients with COVID-19, but further studies are required to validate these findings. Copyright (C) 2021 Elsevier Ltd. All rights reserved.Pathogenesis and treatment of chronic pulmonary disease